We have located links that may give you full text access.
Combining Transoral Outlet Reduction with Pharmacotherapy Yields Similar One-year Efficacy with Improved Safety Compared to Surgical Revision for Weight Regain Following Roux-en-Y Gastric Bypass.
Gastrointestinal Endoscopy 2023 May 6
BACKGROUND AND AIMS: Transoral outlet reduction (TORe) and anti-obesity medication (AOM) are effective treatments for weight regain following Roux-en-Y gastric bypass (RYGB). This study aims to 1) assess the efficacy of combination therapy (TORe + AOM) for treating weight regain and 2) compare the safety and efficacy of combination therapy to AOM alone, TORe alone and surgical revision of RYGB.
METHODS: This was a retrospective study of RYGB patients with weight regain who underwent combination therapy, defined as initiation of at least one AOM within 6 months prior to or after TORe. Outcomes included weight loss following combination therapy and comparison of combination therapy to AOM alone, TORe alone and surgical revision.
RESULTS: 145 RYGB patients underwent combination therapy. Most commonly prescribed AOMs included topiramate, phentermine/topiramate, phentermine and liraglutide. At 12 months, patients experienced 15.2±7.4% TWL. The proportion of patients who achieved ≥5% TWL at 12 months was 90%. Combination therapy was associated with greater weight loss than AOM alone (15.2±7.4% vs 6.8±8.2% TWL, p<0.0001) or TORe alone (15.2±7.4% vs 8.7±8.3% TWL, p<0.0001), with similar SAE rates (2.1% vs 4.7% vs 0.6% for combination therapy vs AOM alone vs TORe alone (p>0.05)). Combination therapy yielded similar weight loss to surgical revision (15.2±7.4% vs 16.4±13.1% TWL, p=0.34), with a lower SAE rate (2.1% vs 14.3%, p=0.0004).
CONCLUSION: Combination of TORe with AOM is superior to either therapy alone providing similar efficacy to surgical revision with a better safety profile for the treatment of weight regain following RYGB.
METHODS: This was a retrospective study of RYGB patients with weight regain who underwent combination therapy, defined as initiation of at least one AOM within 6 months prior to or after TORe. Outcomes included weight loss following combination therapy and comparison of combination therapy to AOM alone, TORe alone and surgical revision.
RESULTS: 145 RYGB patients underwent combination therapy. Most commonly prescribed AOMs included topiramate, phentermine/topiramate, phentermine and liraglutide. At 12 months, patients experienced 15.2±7.4% TWL. The proportion of patients who achieved ≥5% TWL at 12 months was 90%. Combination therapy was associated with greater weight loss than AOM alone (15.2±7.4% vs 6.8±8.2% TWL, p<0.0001) or TORe alone (15.2±7.4% vs 8.7±8.3% TWL, p<0.0001), with similar SAE rates (2.1% vs 4.7% vs 0.6% for combination therapy vs AOM alone vs TORe alone (p>0.05)). Combination therapy yielded similar weight loss to surgical revision (15.2±7.4% vs 16.4±13.1% TWL, p=0.34), with a lower SAE rate (2.1% vs 14.3%, p=0.0004).
CONCLUSION: Combination of TORe with AOM is superior to either therapy alone providing similar efficacy to surgical revision with a better safety profile for the treatment of weight regain following RYGB.
Full text links
Related Resources
Trending Papers
Revascularization Strategy in Myocardial Infarction with Multivessel Disease.Journal of Clinical Medicine 2024 March 27
Intravenous infusion of dexmedetomidine during the surgery to prevent postoperative delirium and postoperative cognitive dysfunction undergoing non-cardiac surgery: a meta-analysis of randomized controlled trials.European Journal of Medical Research 2024 April 19
The Tricuspid Valve: A Review of Pathology, Imaging, and Current Treatment Options: A Scientific Statement From the American Heart Association.Circulation 2024 April 26
Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows.Endocrine Reviews 2024 April 28
Management of Diverticulitis: A Review.JAMA Surgery 2024 April 18
Interstitial Lung Disease: A Review.JAMA 2024 April 23
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app